Horn & Co. represented Pontifax on the deal. Pontifax completed a $30 million Convertible Debt Financing Agreement with ProQR Therapeutics N.V., developing transformative RNA therapies for…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
